Apimeds Pharmaceuticals US APUS
NYSE APUS
$4.16 -0.23 (-5.21%)
At close: Aug 20, 2026 · 11:16 AM UTC

Apimeds Pharmaceuticals US (APUS) Property, Plant & Equipment (Net) (2025)

Apimeds Pharmaceuticals US (APUS) Property, Plant & Equipment (Net) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Haleon 44.05 Bn 43.08 Bn - 2.55 Bn
2 Teva Pharmaceutical Industries 43.39 Bn 39.74 Bn 2.15 Bn 3.93 Bn
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn 3.76 Bn
4 Takeda Pharmaceutical 28.78 Bn 22.99 Bn 5.10 Bn 13.44 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn 1.93 Bn
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn 2.44 Bn
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn 90.50 Mn
8 Elanco Animal Health 11.92 Bn 11.39 Bn 798.00 Mn 1.41 Bn
9 Dr Reddys Laboratories 10.16 Bn 9.99 Bn - 2.96 Bn
10 Apimeds Pharmaceuticals US 7.12 Mn 7.12 Mn - 51,929.00

Historic Data

Download Data
DateValue
Dec 31, 2025 51,626.00
Dec 31, 2025 51,626.00
Sep 30, 2025 34,188.00
Sep 30, 2025 34,188.00
Jun 30, 2025 13,137.00
Jun 30, 2025 13,137.00